Neuroprotective Effect of the n-Hexane Extracts of Laurus nobilis L. in Models of Parkinson's Disease |
Ham, Ah-Rom
(Natural Products Research Institute, College of Pharmacy, Seoul National University)
Shin, Jong-Heon (Natural Products Research Institute, College of Pharmacy, Seoul National University) Oh, Ki-Bong (School of Agricultural Biotechnology, Seoul National University) Lee, Sung-Jin (Department of Animal Biotechnology, Kangwon National University) Nam, Kung-Woo (Natural Products Research Institute, College of Pharmacy, Seoul National University) Koo, Uk (Natural Products Research Institute, College of Pharmacy, Seoul National University) Kim, Kyeong-Ho (College of Pharmacy, Kangwon National University) Mar, Woong-Chon (Natural Products Research Institute, College of Pharmacy, Seoul National University) |
1 | Watanabe, H., Muramatsu, Y., Kurosaki, R., Michimata, M., Matsubara, M., Imai, Y. and Araki T. (2004) Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study. Eur. Neuropsychopharmacol. 14, 93-104. DOI |
2 | Waxman, E. A. and Giasson, B. I. (2010) A novel, high-efficiency cellular model of fibrillar alpha-synuclein inclusions and the examination of mutations that inhibit amyloid formation. J. Neurochem. 113, 374-388. DOI |
3 | Yoshikawa, M., Shimoda, H., Uemura, T., Morikawa, T., Kawahara, Y. and Matsuda, H. (2000) Alcohol absorption inhibitors from bay leaf (Laurus nobilis): structure-requirements of sesquiterpenes for the activity. Bioorg Med. Chem. 8, 2071-2077. DOI |
4 | Yuan, H., Liang, L. W., Chen, Z. J., Ji, H. R., Wang, M. K., Zhang, H. Y., Li, C. and Xu, J. Y. (2006) R-apomorphine protects against 6-hydroxydopamine-induced nigrostriatal damage in rat. Neurosci Bull. 22, 331-338. |
5 | Zbarsky, V., Datla, K. P., Parkar, S., Rai, D. K., Aruoma, O. I. and Dexter, D. T. (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 39, 1119-1125. DOI |
6 | Zhang, Y. and Zhao, B. (2003) Green tea polyphenols enhance sodium nitroprusside-induced neurotoxicity in human neuroblastoma SHSY5Y cells. J. Neurochem. 86, 1189-1200. DOI |
7 | Lo Bianco, C., Schneider, B. L., Bauer, M., Sajadi, A., Brice, A., Iwatsubo, T. and Aebischer, P. (2004) Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease. Proc. Natl. Acad. Sci. USA. 101, 17510-17515. DOI |
8 | Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A. and Mucke L. (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269. DOI |
9 | Mattson, M. P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129. DOI |
10 | Paxinos, G. and Watson C. (1998) The rat brain. Academic Press. |
11 | Sayyah, M., Saroukhani, G., Peirovi, A. and Kamalinejad, M. (2003) Analgesic and anti-inflammatory activity of the leaf essential oil of Laurus nobilis Linn. Phytother. Res. 17, 733-736. DOI |
12 | Sayyah, M., Valizadeh, J. and Kamalinejad, M. (2002) Anticonvulsant activity of the leaf essential oil of Laurus nobilis against pentylenetetrazole- and maximal electroshock-induced seizures. Phytomedicine 9, 212-216. DOI |
13 | Tirmenstein, M. A., Hu, C. X., Scicchitano, M. S., Narayanan, P. K., Mc- Farland, D. C., Thomas, H. C. and Schwartz, L. W. (2005) Effects of 6-hydroxydopamine on mitochondrial function and glutathione status in SH-SY5Y human neuroblastoma cells. Toxicol. In Vitro 19, 471-479. DOI |
14 | Von Coelln, R., Kugler, S., Bahr, M., Weller, M., Dichgans, J. and Schulz, J. B. (2001) Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals. J. Neurochem. 77, 263-273. DOI |
15 | Gomez-Santos, C., Ferrer, I., Santidrian, A. F., Barrachina, M., Gil, J. and Ambrosio, S. (2003) Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. Neurosci. Res. 73, 341-350. DOI |
16 | Guo, S., Yan, J., Yang, T., Yang, X., Bezard, E. and Zhao, B. (2007) Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway. Biol. Psychiatry 62, 1353-1362. DOI |
17 | Hughes, A. J., Bishop, S., Kleedorfer, B., Turjanski, N., Fernandez, W., Lees, A. J. and Stern, G. M. (1993) Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years. Mov. Disord. 8, 165-170. DOI |
18 | Koch, E., Klaas, C. A., Rungeler, P., Castro, V., Mora, G., Vichnewski, W. and Merfort, I. (2001) Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB. Biochem. Pharmacol. 62, 795-801. DOI |
19 | Khan, M. M., Ahmad, A., Ishrat, T., Khan, M. B., Hoda, M. N., Khuwaja, G., Raza, S. S., Khan, A., Javed, H., Vaibhav, K. and Islam, F. (2010) Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res. 1328, 139-151. DOI |
20 | Kobayashi, H., Oikawa, S., Umemura, S., Hirosawa, I. and Kawanishi, S. (2008) Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells. Free Radic. Res. 42, 651-660. DOI |
21 | LeBel, C. P., Ischiropoulos, H. and Bondy, S. C. (1992) Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol 5, 227-231. DOI |
22 | Chu, Y. and Kordower, J. H. (2007) Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? Neurobiol. Dis. 25, 134-149. DOI |
23 | Chu, Y., Le, W., Kompoliti, K., Jankovic, J., Mufson, E. J. and Kordower, J. H. (2006) Nurr1 in Parkinson's disease and related disorders. J. Comp. Neurol. 494, 495-514. DOI |
24 | Conforti, F., Statti, G., Uzunov, D. and Menichini, F. (2006) Comparative chemical composition and antioxidant activities of wild and cultivated Laurus nobilis L. leaves and Foeniculum vulgare subsp. piperitum (Ucria) coutinho seeds. Biol. Pharm. Bull. 29, 2056-2064 DOI |
25 | Dauer, W. and Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron 39, 889-909. DOI |
26 | Gomez-Isla, T., Irizarry, M. C., Mariash, A., Cheung, B., Soto, O., Schrump, S., Sondel, J., Kotilinek, L., Day, J., Schwarzschild, M. A., Cha, J. H., Newell, K., Miller, D. W., Ueda, K., Young, A. B., Hyman, B. T. and Ashe, K. H. (2003) Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice. Neurobiol. Aging 24, 245-258. DOI |
27 | Dedov, V. N., Cox, G. C. and Roufogalis, B. D. (2001) Visualisation of mitochondria in living neurons with single- and two-photon fluorescence laser microscopy. Micron 32, 653-660. DOI |
28 | Desplats, P., Lee, H. J., Bae, E. J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E. and Lee S. J. (2009) Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein. Proc. Natl. Acad. Sci. USA. 106, 13010-13015. DOI |
29 | Golde, T. E. (2009) The therapeutic importance of understanding mechanisms of neuronal cell death in neurodegenerative disease. Mol. Neurodegener. 4, 8. DOI |
30 | Barzilai, A., Melamed, E. and Shirvan, A. (2001) Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease? Cell. Mol. Neurobiol. 21, 215-235. DOI |
31 | Chen, J. J. and Obering, C. (2005) A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease. Clin. Ther. 27, 1710-1724. DOI |